8,11-eicosadienoic acid | 3039-63-2

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 8,11-eicosadienoic acid
• 英文别名: (8E,11E)-icosa-8,11-dienoic acid
• CAS: 3039-63-2
• 化学式: C₂₀H₃₆O₂
• 分子量: 308.505
• InChiKey: XUJWOMMOEOHPFP-OKLKQMLOSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.9
• 重原子数：
  22
• 可旋转键数：
  16
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• Compositions comprising reverse isomers of conjugated linoleic acid
  申请人：Saebo Asgeir

  公开号：US20050215641A1

  公开（公告）日：2005-09-29

  The present invention relates to the field of human and animal nutrition, and in particular to certain novel compositions of conjugated linoleic acids (CLA). In particular, the present invention relates to CLA compositions comprising the c10,t12, c10,c12, t9,c11 and c9,c11 isomers of conjugated linoleic acid.

  本发明涉及人类和动物营养领域，特别是某些新颖的共轭亚油酸（CLA）组合物。具体而言，本发明涉及包含共轭亚油酸的c10,t12、c10,c12、t9,c11和c9,c11异构体的CLA组合物。
• Functional acylglycerides
  申请人：Natural ASA

  公开号：US20030144353A1

  公开（公告）日：2003-07-31

  The present invention relates to the field of human and animal nutrition, and in particular to certain novel compositions of conjugated linoleic acids (CLA). In particular, the present invention relates certain isomers of conjugated linoleic acids at either the SN1 and SN3 or SN2 positions of the acylglyceride molecule and another fatty acyl residue at the other of the SN1 and SN3 or SN2 positions of the acylglyceride molecule. These novel acylglyceride compositions containing conjugated linoleic acyl residues, medium chain fatty acyl residues, long chain fatty acyl residues, and &ohgr;3, &ohgr;6, and &ohgr;9 fatty acyl residues are efficacious as pharmaceutical compositions, animal feed additives, and human dietary supplements.

  本发明涉及人类和动物营养领域，特别是某些共轭亚油酸（CLA）的新型组合物。具体而言，本发明涉及在酰基甘油分子的SN1和SN3或SN2位置上的某些共轭亚油酸异构体以及在酰基甘油分子的SN1和SN3或SN2位置上的另一种脂肪酰残基。这些新型酰基甘油组成物包含共轭亚油酸酰残基、中链脂肪酰残基、长链脂肪酰残基和&ohgr;3、&ohgr;6和&ohgr;9脂肪酰残基，可作为制药组合物、动物饲料添加剂和人类膳食补充剂。
• [EN] BIOLOGICAL FERMENTATION USING DIHYDROXYACETONE AS A SOURCE OF CARBON<br/>[FR] FERMENTATION BIOLOGIQUE UTILISANT DE LA DIHYDROXYACÉTONE COMME SOURCE DE CARBONE
  申请人：KEMBIOTIX LLC

  公开号：WO2017139420A1

  公开（公告）日：2017-08-17

  The present invention relates to the use of hydrocarbons derived from natural gas in the fermentative production of biochemicals including biofuels. More specifically, the present invention provides the method for manufacturing dihydroxyacetone ("DHA") from natural gas, biogas, biomass and CO2 released from industrial plants including electricity-generating plants, steel mills and cement factories and the use of DHA as a source of organic carbon in the fermentative production of biochemicals including biofuels. The present invention comprises three stages. In the first stage of the present invention, syngas and formaldehyde are produced from natural gas, biogas, biomass and CO2 released from industrial plants. In the second stage of the present invention, formaldehyde and syngas are condensed to produce DHA. In the third stage of the present invention, biochemicals including biofuels are produced from DHA using fermentation process involving wild type or genetically modified microbial biocatalysts.

  本发明涉及使用从天然气中提取的碳氢化合物在生物化学品，包括生物燃料的发酵生产中的应用。更具体地说，本发明提供了一种从天然气、沼气、生物质和工业厂房中释放的CO2中制造二羟基丙酮（"DHA"）的方法，以及将DHA作为有机碳源在发酵生产中制造生物化学品，包括生物燃料的应用。本发明包括三个阶段。在本发明的第一阶段中，从天然气、沼气、生物质和工业厂房中释放的CO2中产生合成气和甲醛。在本发明的第二阶段中，甲醛和合成气被凝结成DHA。在本发明的第三阶段中，使用野生型或基因改造的微生物生物催化剂进行发酵过程，从DHA中生产生物化学品，包括生物燃料。
• Formulations and methods for treatment or amelioration of inflammatory conditions
  申请人：Phinney Dodge Stephen

  公开号：US20050137253A1

  公开（公告）日：2005-06-23

  Formulations and methods for the treatment and/or amelioration of symptoms of inflammatory conditions and associated systemic inflammatory responses are described herein. The compositions comprise a non-alpha tocopherol (especially gamma-, beta-, or delta-tocopherol) and one or more of an omega-3 fatty acid, such as docosahexaenoic acid (DHA) or a flavonoid.

  本文描述了用于治疗和/或改善炎症状和相关全身炎症反应的配方和方法。这些组合物包括非α-生育酚（特别是γ-、β-或δ-生育酚）和一种或多种ω-3脂肪酸，例如二十二碳六烯酸（DHA）或类黄酮。
• PHOSPHATIDIC ACID PHOSPHATASE HOMOLOGS AND USE THEREOF
  申请人：Ochiai Misa

  公开号：US20100196579A1

  公开（公告）日：2010-08-05

  The present invention provides novel genes for phosphatidic acid phosphatase. A nucleic acid comprising the nucleotide sequence shown in SEQ ID NO: 1 or 4 or a fragment thereof.

  本发明提供了磷酸甘油酸磷酸酯酶的新基因。其中包括SEQ ID NO:1或4所示的核苷酸序列或其片段的核酸。